{
    "nct_id": "NCT04563130",
    "official_title": "Use of Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer: a Randomized Controlled Trial",
    "inclusion_criteria": "* Gynecologic cancer diagnosis (ovarian, cervical, endometrial cancer; adenocarcinomas of likely primary gynecologic origin based on cytology or FNA in conjunction with radiologic impression will be eligible)\n* Plan to receive at least 6 cycles of paclitaxel administered every 3 weeks at Duke Cancer Institute. Patients receiving neoadjuvant chemotherapy with a plan for interval debulking will be eligible.\n* ECOG performance status of 0-1\n* Latex allergy does not exclude a subject from the study. Non-latex gloves will be provided.\nHealthy volunteers allowed\nMust be FEMALE",
    "exclusion_criteria": "* Treated with prior neurotoxic chemotherapeutic agents\n* Baseline diagnosis of peripheral neuropathy such as diabetic neuropathy, or associated with conditions including but not limited to fibromyalgia, cryoglobulinemia and Raynaud's disease.",
    "miscellaneous_criteria": ""
}